Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: To assess the lower [F]FDG limit in administered activity and/or scan time reduction capabilities of a digital-BGO 32-cm axial field-of-view PET system while being compliant with current and updated EANM Research Ltd Fluorine-18 accreditation specifications (EARL and EARL).

Methods: EARL and EARL compliance of the digital-BGO system (Omni Legend 32 cm) was tested for several reconstructions, including those that apply precision deep learning-based image enhancement (PDL) as postprocessing, using the calibration QC and NEMA IEC phantom measurements. The image quality QC scan was repeated every hour for 7 h, with each subsequent hour representing a lower administered activity, and reconstructed for various times per bed position, i.e. 30, 60, 120, 180, and 300 s. For each of the image quality QC images, coefficient of variation (COV) of the background compartment, and mean, maximum and peak activity concentration recovery coefficients (RC, RC and RC) of differently-sized spheres were calculated and compared to current and updated EARL accreditation specifications.

Results: When we apply 1 min per bed position for PET acquisition, [F]FDG administration can be reduced by a factor of ∼ 4 for EARL, by a factor of ∼ 8 for EARL (2 mm voxels) and by a factor of ∼ 4 for EARL (4 mm voxels) using both standard reconstructions and PDL post-processing compared to current EANM recommendations for [F]FDG administration (7 MBqminbedkg).

Conclusions: Reduction in [F]FDG administered activity is possible by at least a factor 4 for 1 min/bed with the Omni Legend 32 cm PET/CT while maintaining EARL and EARL compliance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmp.2025.104935DOI Listing

Publication Analysis

Top Keywords

administered activity
16
earl compliance
12
earl
10
[f]fdg administered
8
reduction capabilities
8
32-cm axial
8
axial field-of-view
8
maintaining earl
8
current updated
8
earl earl
8

Similar Publications

Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment.

Mol Ther Methods Clin Dev

June 2025

Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan.

Liver-humanized chimeric mice (PXB-mice) are widely utilized for predicting human pharmacokinetics (PK) and as human disease models. However, residual metabolic activity of mouse hepatocytes in chimeric mice can interfere with accurate human PK estimation. Lipid nanoparticle (LNP)-formulated small interfering RNA (siRNA) treatment makes it possible to eliminate the shortcomings of chimeras and create new models.

View Article and Find Full Text PDF

Introduction: Acupuncture has emerged as an effective adjunctive therapy for polycystic ovary syndrome (PCOS) with concern on the higher rate of adverse events (AE). In addition, timing of intervention, specific acupoints, and stimulation strength are concerning, as high-stimulation electroacupuncture (EA) may increase miscarriage risk. This review aims to systematically evaluate the safety profile of acupuncture in PCOS.

View Article and Find Full Text PDF

Introduction: Synovial sarcoma (SS) is one of the most prevalent malignant soft tissue sarcomas in children and adolescents. Pediatric populations often present with atypical features, complicating the differentiation from benign intramuscular venous malformations (VMs).

​​case Presentation: An 11-year-old male with a four-year history of progressive right plantar pain and a compressible intramuscular mass.

View Article and Find Full Text PDF

Target the Heart: A New Axis of Alzheimer's Disease Prevention.

J Dement Alzheimers Dis

June 2025

Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.

Background/objective: Cyclosporine A and other calcineurin inhibitors have been identified as prospective treatments for preventing Alzheimer's disease. We previously found that calcineurin inhibitors elicit a unique behavioral profile in zebrafish larvae, characterized by increased activity, acoustic hyperexcitability, and reduced visually guided behaviors. Screening a large library of FDA-approved compounds using Z-LaP Tracker revealed that some heart medications produce a similar behavioral profile, suggesting these drugs may exert calcineurin-inhibitor-like effects relevant to prevent-ing or ameliorating Alzheimer's disease.

View Article and Find Full Text PDF

Asthma is one of the most prevalent chronic respiratory illnesses, significantly impacting patients through shortness of breath and even death. Acute exacerbations are usually controlled with a short-acting beta agonist, such as an albuterol inhaler, as well as long-acting agents to prevent the occurrence of exacerbations and status asthmaticus. Status asthmaticus is an emergent episode of asthma that is refractory to standard treatment.

View Article and Find Full Text PDF